Allakos (ALLK) Earnings Date & Reports

Industry: @Pharmaceuticals Major

A.I. Advisor

published Earnings

ALLK is expected to report earnings to fall 17.53% to -24 cents per share on November 11

Q3'24

Est.

$-0.25

Q2'24

Beat

by $0.03

Q1'24

Missed

by $0.37

Q4'23

Missed

by $0.24

Q3'23

Missed

by $0.07

The last earnings report on August 08 showed earnings per share of -30 cents, beating the estimate of -33 cents. With 359.59K shares outstanding, the current market capitalization sits at 56.52M.

View a ticker or compare two or three

Compare

ALLK

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For ALLK
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a provider of antibody therapeutics for allergic and inflammatory diseases

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Pharmaceuticals Major

Address

825 Industrial Road

Phone

+1 650 597-5002

Employees

131

Web

https://www.allakos.com